D. Céline, Service de Réanimation Polyvalente

B. Sébastien, Service de Réanimation polyvalente

D. Pierre, Service de Réanimation polyvalente, Allée Jacques Monod 62321

C. Boulle-geronimi, Service de Réanimation polyvalente

L. Guillaume, P. De-cardiologie, C. Hôpital-cardio-thoracique, and . Lille,

V. André, . Pôle-de-cardiologie, C. Hôpital-cardio-thoracique, and . Lille,

B. Steve, P. De-réanimation, H. R. Salengro, and . Chu-de-lille,

P. Vincent, H. R. Pôle-de-réanimation, . Salengro, and . Chu-de-lille,

D. Hervé and R. Polyvalente, France. dupont.herve@chu-amiens.fr Christophe TRIBOUILLOY

P. Marcel, . Cardiology, and F. Chu-amiens-picardie,

P. Chan, J. Ogilby, and B. Segal, Tricuspid valve endocarditis, Am Heart J, vol.117, issue.5, pp.1140-1146, 1989.

D. R. Murdoch, G. R. Corey, B. Hoen, J. M. Miró, V. G. Fowler et al., International collaboration on endocarditis-prospective cohort study (ICE-PCS) investigators. Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the international collaboration on endocarditis-prospective cohort study, Arch Intern Med, vol.169, issue.5, pp.463-73, 2009.

O. Otome, S. Guy, A. Tramontana, G. Lane, and H. Karunajeewa, A retrospective review: significance of vegetation size in injection drug users with rightsided infective endocarditis, Heart Lung Circ, vol.25, issue.5, pp.466-70, 2016.

S. Yamashita, K. Noma, G. Kuwata, K. Miyoshi, and K. Honaga, Infective endocarditis at the tricuspid valve following central venous catheterization, J Anesth, vol.19, issue.1, pp.84-91, 2005.

M. L. Armstrong, S. Deboer, and F. Cetta, Infective endocarditis after body art: a review of the literature and concerns, J Adolesc Health, vol.43, issue.3, pp.217-242, 2008.

J. A. Sandoe, G. Barlow, J. B. Chambers, M. Gammage, A. Guleri et al., British Society for Antimicrobial Chemotherapy; British Heart Rhythm Society; British cardiovascular society; British heart valve society; British Society for Echocardiography. Guidelines for the diagnosis, prevention and management of implantable cardiac electronic device infection, Report of a joint working party project on behalf of the British Society for Antimicrobial Chemotherapy (BSAC, host organization), vol.70, pp.325-59, 2015.

S. T. Hussain, J. Witten, N. K. Shrestha, E. H. Blackstone, and G. B. Pettersson, Tricuspid valve endocarditis, Ann Cardiothorac Surg, vol.6, issue.3, pp.255-61, 2017.

R. Moss and B. Munt, Injection drug use and right sided endocarditis, Heart, vol.89, issue.5, pp.577-81, 2003.

C. Ortiz, J. López, H. García, T. Sevilla, A. Revilla et al., Clinical classification and prognosis of isolated right-sided infective endocarditis, Medicine (Baltimore), vol.93, issue.27, p.137, 2014.

G. Saydain, J. Singh, B. Dalal, W. Yoo, and D. P. Levine, Outcome of patients with injection drug use-associated endocarditis admitted to an intensive care unit, J Crit Care, vol.25, issue.2, pp.248-53, 2010.

B. Mourvillier, J. L. Trouillet, J. F. Timsit, J. Baudot, J. Chastre et al., Infective endocarditis in the intensive care unit: clinical spectrum and prognostic factors in 228 consecutive patients, Intensive Care Med, vol.30, issue.11, pp.2046-52, 2004.

A. Samol, S. Kaese, J. Bloch, D. Görlich, G. Peters et al., Infective endocarditis on ICU: risk factors, outcome and long-term follow-up, Infection, vol.43, issue.3, pp.287-95, 2015.

G. Habib, P. Lancellotti, M. J. Antunes, M. G. Bongiorni, J. P. Casalta et al., ESC guidelines for the Management of Infective Endocarditis: the task force for the management of infective endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM), Eur Heart J, vol.36, issue.44, pp.3075-128, 2015.

L. M. Baddour, W. R. Wilson, A. S. Bayer, V. G. Fowler, I. M. Tleyjeh et al., American Heart Association Committee on rheumatic fever, endocarditis, and Kawasaki disease of the council on cardiovascular disease in the young, council on clinical cardiology, council on cardiovascular surgery and anesthesia, and stroke council, Circulation, vol.132, issue.15, pp.1435-1486, 2015.

J. S. Li, D. J. Sexton, M. N. Nettles, R. Fowler, V. G. Ryan et al., Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis, Clin Infect Dis, vol.30, issue.4, pp.633-641, 2000.

L. Gall, J. R. Lemeshow, S. Saulnier, and F. , A new simplified acute physiology score (SAPS II) based on a European/north American multicenter study, JAMA, vol.270, issue.24, pp.2957-63, 1993.

J. L. Vincent, R. Moreno, J. Takala, S. Willatts, D. Mendonça et al., The SOFA (sepsis-related organ failure assessment) score to describe organ dysfunction/failure. On behalf of the working group on sepsis-related problems of the European Society of Intensive Care Medicine, Intensive Care Med, vol.22, issue.7, pp.707-717, 1996.

M. E. Charlson, P. Pompei, K. L. Ales, and C. R. Mackenzie, A new method of classifying prognostic comorbidity in longitudinal studies: development and validation, J Chronic Dis, vol.40, pp.373-83, 1987.

W. A. Zoghbi, M. Enriquez-sarano, E. Foster, P. A. Grayburn, C. D. Kraft et al., American Society of Echocardiography, J Am Soc Echocardiogr, vol.16, issue.7, pp.777-802, 2003.

J. M. Miró, A. Del-río, and C. A. Mestres, Infective endocarditis and cardiac surgery in intravenous drug abusers and HIV-1 infected patients, Cardiol Clin, vol.21, issue.2, pp.167-84, 2003.

F. Guerrero, M. L. , G. López, J. J. Goyenechea, A. Fraile et al., Endocarditis caused by Staphylococcus Aureus: a reappraisal of the epidemiologic, clinical, and pathologic manifestations with analysis of factors determining outcome, Medicine (Baltimore), vol.88, issue.1, pp.1-22, 2009.

M. A. Sande, . Nafcillin-gentamicin, and . Ckb, Synergism in experimental staphylococcal endocarditis, J Lab Clin Med, vol.88, issue.1, pp.118-142, 1976.

O. Korzeniowski and M. A. Sande, Combination antimicrobial therapy for Staphylococcus Aureus endocarditis in patients addicted to parenteral drugs and in nonaddicts: a prospective study, Ann Intern Med, vol.97, issue.4, pp.496-503, 1982.

E. Ribera, J. Gómez-jimenez, E. Cortes, O. Del-valle, A. Planes et al., Effectiveness of cloxacillin with and without gentamicin in short-term therapy for right-sided Staphylococcus Aureus endocarditis. A randomized, controlled trial, Ann Intern Med, vol.125, issue.12, pp.969-74, 1996.

S. E. Cosgrove, G. A. Vigliani, V. G. Fowler, A. E. Corey, G. R. Levine et al., Initial low-dose gentamicin for Staphylococcus Aureus bacteremia and endocarditis is nephrotoxic, Clin Infect Dis, vol.48, issue.6, pp.713-721, 2009.

P. Tattevin and J. L. Mainardi, Analysis of the 2015 American and European guidelines for the management of infective endocarditis, Med Mal Infect, vol.46, issue.8, pp.406-416, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01494110

P. Martín-dávila, E. Navas, J. Fortún, J. L. Moya, J. Cobo et al., Analysis of mortality and risk factors associated with native valve endocarditis in drug users: the importance of vegetation size, Am Heart J, vol.150, issue.5, pp.1099-106, 2005.

M. Musci, H. Siniawski, M. Pasic, O. Grauhan, Y. Weng et al., Surgical treatment of right-sided active infective endocarditis with or without involvement of the left heart: 20-year single center experience, Eur J Cardiothorac Surg, vol.32, issue.1, pp.118-143, 2007.

A. Revilla, J. López, E. Villacorta, I. Gómez, T. Sevilla et al., Isolated right-sided valvular endocarditis in non-intravenous drug users, Rev Esp Cardiol, vol.61, issue.12, pp.1253-1262, 2008.

D. Horstkotte, F. Follath, E. Gutschik, M. Lengyel, A. Oto et al., Task force members on infective endocarditis of the European Society of Cardiology; ESC Committee for practice guidelines (CPG); document reviewers. Guidelines on prevention, diagnosis and treatment of infective endocarditis executive summary; the task force on infective endocarditis of the European society of cardiology, Eur Heart J, vol.25, issue.3, pp.267-76, 2004.

L. M. Baddour, W. R. Wilson, A. S. Bayer, V. G. Fowler, A. F. Bolger et al., Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease; Council on Cardiovascular Disease in the Young, Stroke, and Cardiovascular Surgery and Anesthesia

, Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, Infectious Diseases Society of America, vol.111, pp.394-434, 2005.